Iroko's lower dose pain drug Tivorbex obtains FDA approval

US-based Iroko Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) to use Tivorbex (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20mg and 40mg doses to treat mild to moderate acute pain in…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news